Lv5
1280 积分 2023-03-03 加入
Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancer
6天前
已完结
Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR × LGR5 bispecific antibody with efficacy in epithelial tumors
1个月前
已完结
Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
1个月前
已完结
CD19 CAR T-Cell Therapy in Multidrug-Resistant Ulcerative Colitis
2个月前
已完结
The race to reset autoimmune diseases
2个月前
已完结
Analysis of China-to-West pharmaceutical licensing deals in 2024
3个月前
已完结
Quantitative prediction of therapeutic antibody pharmacokinetics after intravenous and subcutaneous injection in human
3个月前
已完结
Pharmacokinetic models for first-in-human dose selection of immune-activating products in oncology
3个月前
已完结
Teclistamab, a B-cell maturation antigen × CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MajesTEC-1): a multicentre, open-label, single-arm, phase 1 study
3个月前
已完结
Navigating the complexities of drug development for inflammatory bowel disease
3个月前
已完结
皖公网安备34019202002308
